Cost-Effectiveness of Plurogel® - A New Micelle-Matrix-Based Dressing With 1% Silver Sulphadiazine – In The Management of Non-Healing Wounds

Abstract

A597economic, and epidemiologic outcomes in NSI were included. Subsequently, a decision tree was developed to estimate and compare the yearly costs incurred while using safety engineered device needle devices (SED) compared to non-SED. For this cost impact analysis, we quantified the annual total direct medical cost per HCW per NSI. Results: The prevalence and frequency of NSI in India ranged from 61 % to 79.5% and 2.3 to 4.5 per HCW per year respectively. Incidence density was 228.57 per 100 person days. 79.5% to 90.5% HCWs reported having at least one NSI in their career. In a hypothetical cohort of 100 HCWs, costs per HCW per year per NSI episode avoided was ₹ (Indian Rupee) 47,861($744). The components comprising this cost element were costs incurred due to injecting needle, suturing needle, cannula, and other needles, respectively as per the literature. Hence, the breakdown of ₹ 47,861 were estimated as ₹ 23,930